Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.40 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 6/20 | 0.37 |
| ▸ | HTR2C | P28335 | 6/20 | 0.37 |
| ▸ | HRH1 | P35367 | 4/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1411892 | 1.00 | DRD2 (0.47) | DRD2DRD3CYP3A4MAOAMAOB | |
| SCHEMBL1249193 | 1.00 | DRD2 (0.47) | DRD2DRD3CYP3A4MAOAMAOB | |
| SCHEMBL1249191 | 1.00 | DRD2 (0.47) | DRD2DRD3CYP3A4MAOAMAOB | |
| SCHEMBL12891390 | 0.84 | MAPT (0.47) | DRD2DRD3CYP3A4MAOAMAOB | |
| SCHEMBL232991 | 0.84 | CYP3A4 (0.68) | CYP3A4MAOAMAOBMAPTMAPK1 | |
| SCHEMBL12810063 | 0.80 | MAPT (0.70) | DRD2DRD3CYP3A4MAOAMAOB | |
| SCHEMBL13825739 | 0.78 | DRD2 (0.53) | DRD2DRD3CYP3A4LTB4RLTB4R2 | |
| SCHEMBL8228508 | 0.78 | DRD2 (0.53) | DRD2DRD3CYP3A4LTB4RLTB4R2 | |
| SCHEMBL8231800 | 0.78 | DRD2 (0.53) | DRD2DRD3CYP3A4LTB4RLTB4R2 | |
| SCHEMBL8232785 | 0.78 | DRD2 (0.53) | DRD2DRD3CYP3A4LTB4RLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| US-12474287-B2 | Detection device and methods of use thereof | AMULET, INC. (US) | 2025-11-18 | — | — | US | claimed |
| EP-3908251-B1 | PHARMACEUTICAL DELIVERY COMPOSITIONS AND USES THEREOF | INNOVACORIUM INC (US) | 2025-08-27 | — | — | EP | claimed |
| CN-120131496-A | Composition for improving skin problems caused by unbalanced skin homeostasis and preparation method thereof | 中央民族大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119950479-A | Application of midecarin in preparing gastric cancer medicine for inhibiting proliferation of human gastric cancer cell HGC-27 | 广东医科大学附属医院 | 2025-05-09 | — | — | CN | claimed |
| WO-2025090945-A1 | FORMULATIONS HAVING A GLYCOSIDE AND A LIPOPHILIC COMPONENT | SPOKE SCIENCES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| CN-119776315-A | Enzyme for synthesizing glabridin | 清华大学 | 2025-04-08 | — | — | CN | claimed |
| CN-119745895-A | Traditional Chinese medicine monomer composition for treating rheumatoid arthritis and application thereof | 中日友好医院(中日友好临床医学研究所) | 2025-04-04 | — | — | CN | claimed |
| CN-115068588-B | Application of cytisine effective component in preparing HPV (human papillomavirus) resistant gel | 江西康林药业有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-115109809-B | Midecarin is a biosynthesis method of (2) | 南京中医药大学 | 2025-03-04 | — | — | CN | claimed |
| CN-116448899-A | Radix astragali preparation fingerprint detection method | 内蒙古壹善药业有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-114965763-B | Traditional Chinese medicine composition for treating oral pharyngitis and multi-index quantitative determination method | 贵州三力制药股份有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-115851572-A | Method for increasing glabridin content in suspension culture cell of liquorice | 甘肃泛植制药有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-11560342-B2 | Bacillus isolates and uses thereof | MONSANTO TECHNOLOGY, LLC (US) | 2023-01-24 | — | — | US | claimed |
| CN-115109809-A | Biosynthesis method of santalin | 南京中医药大学 | 2022-09-27 | — | — | CN | claimed |
| CN-114949030-A | Chickpea effective part and preparation method and application thereof | 广州中医药大学(广州中医药研究院) | 2022-08-30 | — | — | CN | claimed |
| CN-114965763-A | Traditional Chinese medicine composition for oropharyngeal inflammatory diseases and multi-index quantitative determination method | 贵州三力制药股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-114942288-A | Internal plasma medicine chemical component of Kaihoujian spray and its confirmation method | 贵州三力制药股份有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-114478567-A | Method for preparing pterocarpan compounds of Korean sophoricine and Meidi pterocarpan from chickpea sprouts | 中国科学院新疆理化技术研究所 | 2022-05-13 | — | — | CN | claimed |
| CN-113980739-A | Flower fragrance essence with fresh flower style aromatic charm and preparation method thereof | 厦门琥珀日化科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11560342-B2 | Bacillus isolates and uses thereof | BLVRB, BROX, GLB1 | DRD2 3371/4885DRD3 2829/4885CYP3A4 3878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.